Related references
Note: Only part of the references are listed.Hepcidin: another culprit for complications in patients with chronic kidney disease?
Takeshi Nakanishi et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2011)
Effects of end-stage renal disease and haemodialysis on dendritic cell subsets and basal and LPS-stimulated cytokine production
Sudhanshu Agrawal et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Effect of end-stage renal disease on B-lymphocyte subpopulations, IL-7, BAFF and BAFF receptor expression
Madeleine V. Pahl et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2010)
Lipid Peroxidation Products Formation with Various Intravenous Iron Preparations in Chronic Kidney Disease
Anirban Ganguli et al.
RENAL FAILURE (2009)
Intravenous iron exacerbates oxidative DNA damage in peripheral blood lymphocytes in chronic hemodialysis patients
Ko-Lin Kuo et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2008)
The comparative safety of various intravenous iron preparations in chronic kidney disease patients
Anirban Ganguli et al.
RENAL FAILURE (2008)
Effect of repeated intravenous iron administration in haemodialysis patients on serum 8-hydroxy-2′-deoxyguanosine levels
Yukio Maruyama et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2007)
Comparison of oxidative stress markers after intravenous administration of iron dextran, sodium ferric gluconate, and iron sucrose in patients undergoing hemodialysis
Amy Barton Pai et al.
PHARMACOTHERAPY (2007)
Impact of iron sucrose therapy on leucocyte surface molecules and reactive oxygen species in haemodialysis patients
Galip Guz et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2006)
Naive and central memory T-cell lymphopenia in end-stage renal disease
J-W Yoon et al.
KIDNEY INTERNATIONAL (2006)
Neutrophil dysfunction and infection risk in end-stage renal disease
Michel Chonchol
SEMINARS IN DIALYSIS (2006)
Proinflammatory effects of iron sucrose in chronic kidney disease
R Agarwal
KIDNEY INTERNATIONAL (2006)
Oxidative stress and renal injury with intravenous iron in patients with chronic kidney disease
R Agarwal et al.
KIDNEY INTERNATIONAL (2004)
Aberrant T cell activation and heightened apoptotic turnover in end-stage renal failure patients: a comparative evaluation between non-dialysis, haemodialysis, and peritoneal dialysis
B Moser et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
High-dose parenteral iron sucrose depresses neutrophil intracellular killing capacity
R Deicher et al.
KIDNEY INTERNATIONAL (2003)
Induction of protein oxidation by intravenous iron in hemodialysis patients: Role of inflammation
D Tovbin et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2002)
Increase in plasma esterified F2-isoprostanes following intravenous iron infusion in patients on hemodialysis
AK Salahudeen et al.
KIDNEY INTERNATIONAL (2001)
T-cell activation follows Th1 rather than Th2 pattern in haemodialysis patients
U Sester et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2000)
Share Paper
